catlady91 Posted June 27, 2020 Share Posted June 27, 2020 My mum was diagnosed with stage 3B squamous cell non-small cell lung cancer in Feb. She's doing well; she finished her chemo and radiotherapy a while ago and recently started immunotherapy. My mum's biomarkers showed that she has PDL1, which is why they approved her for immunotherapy. A lot of people talk about mutations, but apparently squamous cell doesn't tend to have any mutations. My mum is EDGF wildtype which means that she doesn't have that mutation. Is this a bad thing when it comes to trying to cure or to treat lung cancer? Does having mutations mean that there's more of a chance for cure? Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.